Shilajit/Fulvic Acid / GSH Cancer Research Results

FulvicA, Shilajit/Fulvic Acid: Click to Expand ⟱
Features:
Fulvic acid is a naturally occurring compound found in soil, compost, and marine sediments. It is a complex mixture of many organic acids and has been studied for its antioxidant, anti-inflammatory, and immune-modulating properties.
Shilajit is a complex mineral–organic exudate found in mountainous regions (e.g., Himalayas). It contains fulvic acids, humic substances, dibenzo-α-pyrones (DBPs), trace minerals, and other low-molecular-weight compounds. Most standardized extracts are characterized by fulvic acid content (often 15–60%).

AD:
-Fulvic acid may help inhibit tau fibril formatio
-Antioxidant activity
-Anti-inflammatory effects

Cancer:
-Fulvic acid’s role in reducing drug resistance and improving drug absorption has been suggested
-Synergistic effects with chemotherapy

Fulvic Acid database results: Note how it is antioxidant for normal cells, but may produce ROS in cancer cells. (explains synergistic effect with chemo)
LeafSource Fulvic Acid note how they use Fulvic Acid to improve bioavailability of berberine.

Rank Pathway / Axis Cancer / Tumor Context Normal Tissue Context TSF Primary Effect Notes / Interpretation
1 Mitochondrial function / electron transport support Bioenergetic modulation (context-dependent) ATP production support ↑ (reported) P, R Mitochondrial optimization Dibenzo-α-pyrones and fulvic acids are reported to support mitochondrial respiration in non-cancer models.
2 Nrf2 / antioxidant response Redox tone modulation (model-dependent) Nrf2 ↑; antioxidant enzymes ↑ R, G Redox buffering Commonly described as antioxidant; tumor-direction effects are not well established.
3 NF-κB inflammatory signaling NF-κB ↓ (reported; limited cancer data) Inflammation tone ↓ R, G Anti-inflammatory modulation Anti-inflammatory effects are better documented than direct tumor cytotoxicity.
4 ROS modulation ROS ↓ or stabilized (context-dependent) Oxidative stress ↓ P, R, G Antioxidant effect Acts primarily as redox stabilizer rather than ROS generator.
5 AMPK / metabolic stress pathways Metabolic modulation (limited direct tumor evidence) Energy homeostasis support ↑ R, G Metabolic adaptation Some reports suggest improved metabolic efficiency; not a primary oncologic mechanism.
6 Cell-cycle / apoptosis Apoptosis ↑ (reported in limited preclinical studies) ↔ G Conditional cytotoxicity Data are sparse and largely cell-line based; not a strong, consistent cytotoxic signature.
7 Immune modulation Immune tone modulation (context-dependent) Immune support ↑ R, G Adaptogenic effect Traditional use emphasizes immune and vitality support rather than direct anticancer activity.
8 Metal chelation / mineral transport Trace mineral transport effects (uncertain tumor relevance) Mineral absorption modulation P Biochemical modulation Fulvic acid has chelation properties; relevance to oncology unclear.
9 Quality / contamination risk Variable depending on preparation Heavy metal exposure risk if unrefined — Safety constraint Crude shilajit may contain heavy metals; purified standardized extracts preferred.
10 Bioavailability variability Systemic exposure varies by extraction/purification — — Translation constraint Composition varies widely; standardization typically based on fulvic acid content.

Time-Scale Flag (TSF): P / R / G

  • P: 0–30 min (rapid mitochondrial/redox interactions)
  • R: 30 min–3 hr (acute signaling and metabolic shifts)
  • G: >3 hr (gene-regulatory adaptation and phenotype outcomes)
GSH, Glutathione: Click to Expand ⟱
Source:
Type:
Glutathione (GSH) is a thiol antioxidant that scavenges reactive oxygen species (ROS), resulting in the formation of oxidized glutathione (GSSG). Decreased amounts of GSH and a decreased GSH/GSSG ratio in tissues are biomarkers of oxidative stress.
Glutathione is a powerful antioxidant found in every cell of the body, composed of three amino acids: cysteine, glutamine, and glycine. It plays a crucial role in protecting cells from oxidative stress, detoxifying harmful substances, and supporting the immune system.
cancer cells can have elevated levels of glutathione, which may help them survive in the oxidative environment created by the immune response and chemotherapy. This can make cancer cells more resistant to treatment.
While glutathione can be obtained from certain foods (like fruits, vegetables, and meats), its absorption from supplements is debated. Some people take N-acetylcysteine (NAC) or other precursors to boost glutathione levels, but the effects on cancer prevention or treatment are still being studied.
Depleting glutathione (GSH) to raise reactive oxygen species (ROS) is a strategy that has been explored in cancer research and therapy.
Many cancer cells have altered redox states and may rely on GSH to survive. Increasing ROS levels can induce stress in these cells, potentially leading to cell death.
Certain drugs and compounds can deplete GSH levels. For example, agents like buthionine sulfoximine (BSO) inhibit the synthesis of GSH, leading to its depletion.
Cancer cells tend to exhibit higher levels of intracellular GSH, possibly as an adaptive response to a higher metabolism and thus higher steady-state levels of reactive oxygen species (ROS).

"...intracellular glutathione (GSH) exhibits an astounding antioxidant activity in scavenging reactive oxygen species (ROS)..."
"Cancer cells have a high level of GSH compared to normal cells."
"...cancer cells are affluent with high antioxidant levels, especially with GSH, whose appearance at an elevated concentration of ∼10 mM (10 times less in normal cells) detoxifies the cancer cells." "Therefore, GSH depletion can be assumed to be the key strategy to amplify the oxidative stress in cancer cells, enhancing the destruction of cancer cells by fruitful cancer therapy."

The loss of GSH is broadly known to be directly related to the apoptosis progression.
Scientific Papers found: Click to Expand⟱
4028- FulvicA,    Mineral pitch induces apoptosis and inhibits proliferation via modulating reactive oxygen species in hepatic cancer cells
- in-vitro, Liver, HUH7
Apoptosis↑, TumCP↓, ROS↑, NO↑, Dose↝, MMP↓, Cyt‑c↑, SOD↓, Catalase↓, GSH↑, lipid-P↑, miR-21↓, miR-22↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

Catalase↓, 1,   GSH↑, 1,   lipid-P↑, 1,   ROS↑, 1,   SOD↓, 1,  

Mitochondria & Bioenergetics ⓘ

MMP↓, 1,  

Cell Death ⓘ

Apoptosis↑, 1,   Cyt‑c↑, 1,  

Transcription & Epigenetics ⓘ

miR-21↓, 1,  

Migration ⓘ

miR-22↑, 1,   TumCP↓, 1,  

Angiogenesis & Vasculature ⓘ

NO↑, 1,  

Drug Metabolism & Resistance ⓘ

Dose↝, 1,  
Total Targets: 13

Pathway results for Effect on Normal Cells:


Total Targets: 0

Scientific Paper Hit Count for: GSH, Glutathione
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:358  Target#:137  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page